CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy: Then in 2013, Querol et al. identified antibodies against CNTN1 or the CNTN1/Caspr1 complex which were considered as susceptible to explain the symptoms and signs of three CIDP patients [33].